Fig. 11.
Effect of GPX3 on autophagy and ferroptosis of prostate in vivo. Representative IHC images of GPX4 A and Nrf2 B in prostate of Con, testosterone (T), T + RAS-selective lethal 3 (RSL3), T + troglitazone (TRO) and T + RSL3 + TRO-treated rats group. The quantitative analysis of GPX4 C and Nrf2 D expression in each group rat prostates. E Relative densitometric quantification of GPX4, Nrf2, SOD2 and CAT in prostate of each treatment group. The content of iron F, MDA G and GSH H in prostate of each treatment group were detected by colorimetric assay kit. The results indicated that the ferroptosis and OS levels in the prostate of T-BPH rats could be aggravated by RSL3 treatment, while inhibited by up-regulation of GPX3 in vivo. Representative IHC images of LC3B I and Beclin1 J in prostate of each treatment group. The quantitative analysis of LC3B K and Beclin1 L expression in each group rat prostates. M Relative densitometric quantification of LC3B and Beclin1 in prostate of each treatment group. The results showed that the autophagy level in the prostate of T-BPH rats could be aggravated by RSL3 treatment, while inhibited by up-regulation of GPX3 in vivo. *p < 0.05, **p < 0.01, ***p < 0.001. The scale bars are 400 μm